Sandbox:Gunnam: Difference between revisions

Jump to navigation Jump to search
Gunnam (talk | contribs)
No edit summary
Gunnam (talk | contribs)
Line 34: Line 34:


*
*
===Other  Common Causes are :===
===Other  Common Causes are :===
*Medications like Tamoxifen ,corticosteriods , methotrxate  
*Medications like Tamoxifen ,corticosteriods , methotrxate  

Revision as of 16:28, 16 November 2017


Nonalcoholic fatty liver disease

Overview

Nonalcoholic fatty liver disease [NAFLD] is due to the deposition of extra fat in liver cells that is not caused by alcohol. It is normal for the liver to contain some fat. However, when there is more than 5 -10 percent of the liver’s weight is fat, then it is called a fatty liver (steatosis).NAFLD is marked by inflammation that can progress to irreversible damage.NAFLD is similar to the damage caused by alcohol consumption in most of the cases. It is estimated that in united states approximately 80 to 100 million people are affected with NAFLD. NAFLD most commonly affects people in the age group 2-19 and 40-50 years.It is most commonly seen in Hispanic population when compared to Caucasian and African American populations

Historical Perspective

  • NAFLD is relatively new concept first introduced in 1980.
  • Based on histology it is classified into the non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH).NAFL mostly considered as a benign condition but recent studies show it can progress to NASH up to 44%. The more severe form of NAFLD is called non-alcoholic steatohepatitis (NASH).[1]
  • One of the leading cause for cirrhosis in adults in united states is NASH. Almost 25 percent of adults with NASH may lead to cirrhosis.
  • On the other hand, NASH progress to fibrosis that can lead to cirrhosis and hepatocellular cancer (HCC).[2]
  • Rate of progression does not correlate with body mass index (BMI) or hyperlipidemia

Pathophysiology

  • It is thought that pathophysiology of NAFLD is multifactorial that includes numerous genetic, dietary, metabolic and hormonal factors.
  • Most experts believe that NAFLD is a 2 hit hypothesis.
    • The first hit resulting in increased fat accumulation especially triglycerides within the hepatocyte and increases the risk of liver injury.
    • On the second hit inflammatory cytokines causes mitochondrial dysfunction and oxidative stress which in turn lead to steatohepatitis and/or fibrosis.[3].
  • Free fatty acids (FFA) play very crucial role in damaging the liver indirectly by either undergoing β-oxidation or are esterified with glycerol to form triglycerides, leading to hepatic fat accumulation.
  • Now there is new evidence that FFA is directly causing the liver damage by increasing the oxidative stress by upregulation of TNF-alpha expression via a lysosomal pathway.

[4]

  • Oxidative stress inhibits the replication process in the mature hepatocytes, Results in the proliferation of progenitor (oval ) cell population and later they differentiate into hepatocyte-like cells. Now both the oval and hepatocyte-like cells play a very important role in the process of fibrosis and hepatocellular carcinogenesis.[3]
  • Alterations in MTP/apoB synthesis and secretion have been implicated as one of the potential mechanisms in the pathogenesis of NAFLD which in turn leads to a decreased capacity for lipid export
  • Normally triglycerides are transported from the liver in the form of VLDL particles which are then formed by the incorporation of triglyceride into apolipoprotein B (apoB) by microsomal transfer protein (MTP).[5]

Risk Factors

Other Common Causes are :

  • Medications like Tamoxifen ,corticosteriods , methotrxate
  • Viral Hepatitis.
  • Rapid weight loss.
  • Malnutrition.


Signs and Symptoms

Usually, NAFLD [Nonalcoholic fatty liver disease] presents with no or few symptoms and sighs but when it does it shows the following[11]

  • Hepatomegaly
  • Patient presents with fatigue
  • Abdominal swelling (ascites)
  • Enlarged breasts in men ( due to decreased estrogen clearance by liver damage )
  • Pain in the upper right abdomen
  • Yellowing of the skin and eyes (jaundice)
  • Enlarged spleen (usually observed by a physician during physical exam)

PREVENTION

There are some ways to prevent NAFLD,

  • Eating a healthy diet is the first and very important step.
  • Exercise on regular basis.
  • Maintain a healthy weight.
  • Alcohol cessation, If Patient drinks.
  • Take medications under the guidance of physician when needed,don't take unnecessary medications .
  1. "American Liver Foundation - Non-Alcoholic Fatty Liver Disease".
  2. "Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. - PubMed - NCBI".
  3. 3.0 3.1 Dowman JK, Tomlinson JW, Newsome PN (2010). "Pathogenesis of non-alcoholic fatty liver disease". QJM. 103 (2): 71–83. doi:10.1093/qjmed/hcp158. PMC 2810391. PMID 19914930.
  4. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ (2004). "Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway". Hepatology. 40 (1): 185–94. doi:10.1002/hep.20283. PMID 15239102.
  5. "Apolipoprotein synthesis in nonalcoholic steatohepatitis - Charlton - 2002 - Hepatology - Wiley Online Library".
  6. "Nonalcoholic Fatty Liver Disease".
  7. Sung KC, Jeong WS, Wild SH, Byrne CD (2012). "Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes". Diabetes Care. 35 (4): 717–22. doi:10.2337/dc11-1853. PMC 3308286. PMID 22338098.
  8. "Nonalcoholic fatty liver disease".
  9. "Nonalcoholic Fatty Liver Disease".
  10. "Nonalcoholic Fatty Liver Disease & NASH | NIDDK".
  11. "Nafld".

Diagnosis

 
Incidental finding of Fatty liver on ultrasound
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check for persistently raised LFTs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ask the patient for significant alcohol intake
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO
 
 
 
YES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnose NAFLD
 
 
 
Consider other
alcoholic related diseases


Monitor severity of the disease


 
 
 
 
 
Offer Enhanced Liver Fibrosis Test (ELF)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(>10.51) ELF Positive
 
 
 
(<10.51) ELF Negative
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Indicating advanced fibrosis and risk of progression to cirrhosis
 
 
 
Typically Benign -- Advanced fibrosis unlikely
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Refer the patient to Heptologist
 
 
 
 
  • On negative ELF test offer retest for every 3 years for adults and 2 years for children.